Evenamide (NW-3509) is an orally available voltage-gated sodium channel (VGSC) blocker (Ki=0.4 µM) for the research of schizophrenia. Evenamide shows efficacy in a broad spectrum of rodent models of psychosis, mania, depression, and aggressiveness[1][2].
Molecular Weight:
278.39
Purity:
96.45
CAS Number:
[1092977-61-1]
Formula:
C16H26N2O2
Target:
Sodium Channel
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted